TC Quinn, P Piot, JB McCormick, FM Feinsod, H … - Jama, 1987 - Am Med Assoc Serologic and immunologic studies were performed in 38 African and 60 US patients with acquired
immunodeficiency syndrome (AIDS), 100 African and 100 US heterosexual men and women, and 100 US
homosexual men to examine the ... Cited by 192 - Related articles - All 6 versions
S Pahwa, K Biron, W Lim, P Swenson, MH Kaplan, N … - JAMA, 1988 - Am Med Assoc Acyclovir has become the treatment of choice for varicella-zoster virus (VZV) infections in
immunocompromised individuals. This article describes a 4-year-old girl congenitally infected with
human immunodeficiency virus who ... Cited by 121 - Related articles - All 3 versions
JL Meier, SE Straus - The Journal of infectious diseases, 1992 - jstor.org Page 1. S13 Comparative Biology of Latent Varicella-Zoster Virus and Herpes Simplex Virus
Infections Jeffery L. Meier and Stephen E. Straus Medical Virology Section, Laboratory of
Clinical Investigation, National Institute of Allergy and Infectious ... Cited by 80 - Related articles - All 3 versions
JJ Perna, ML Mannix, JF Rooney, AL Notkins, SE … - Journal of the American …, 1987 - Elsevier Infection with herpes simplex virus often results in a latent infection of local sensory ganglia and
a disease characterized by periodic viral reactivation and mucocutaneous lesions. The factors that
trigger reactivation in humans are ... Cited by 74 - Related articles - All 6 versions
- ►nih.gov [PDF] DP Hajjar - The American journal of pathology, 1991 - pubmedcentral.nih.gov Human atherogenesis is apleiotropicprocess with an undefined cause. Several pathologic factors have
been linked to the diseaseprocess; including arterial injury or activation of the endothelium,
whichmay initiate ... Cited by 79 - Related articles - All 4 versions
SE Straus, KD Croen, MH Sawyer, AG Freifeld, JM … - Jama, 1988 - Am Med Assoc Forty-seven patients with frequently recurring genital herpes participated in one or more of five
sequential trials of oral suppressive therapy with 200 mg of acyclovir three times daily from four
to 12 months' duration. The ... Cited by 62 - Related articles - All 3 versions
PJ Selby, RL Powles, D Easton, TJ Perren, … - British journal of …, 1989 - pubmedcentral.nih.gov Eighty-two patients were randomly allocated to receive intravenous acyclovir 5 mg kg-1 tds for 23
days followed by oral acyclovir 800 mg 6-hourly for 6 months or matching placebos after allogeneic
bone marrow transplantation. Herpes ... Cited by 43 - Related articles - All 3 versions
SE Straus, B Savarese, M Tigges, AG Freifeld, PR … - The Journal of infectious …, 1993 - jstor.org Induction and Enhancement of Immune Responses to Herpes Simplex Virus ... Type 2 in Humans by Use
of a Recombinant Glycoprotein D Vaccine ... Stephen E. Straus, Barbara Savarese, Michael Tigges,
Alison G. Freifeld, Philip R. ... Cited by 45 - Related articles - BL Direct - All 4 versions
RJ Whitley, DW Kimberlin - Seminars in pediatric infectious diseases, 2005 - Elsevier Herpes simplex encephalitis (HSE) remains one of the most devastating infections of the central
nervous system despite available antiviral therapy. Children and adolescents account for
approximately one third of all ... Cited by 42 - Related articles - All 15 versions
LR Stanberry, DM Jorgensen, AJ Nahmias - Viral infections of humans. … - books.google.com CHAPTER 14 Herpes Simplex Viruses 1 and 2 Lawrence R. Stanberry, Daniel M. Jorgensen, and Andre J.
Nahmias 1. Introduction and Social Significance Herpes simplex virus (HSV) infections are among the
most common communicable diseases ... Cited by 41 - Related articles
